The latest updates on our research and how it is improving people’s lives.
24 June 2019
Researchers at NDORMS and their international partners have been awarded USD1.7 million by the Chan Zuckerberg Initiative (CZI) to unveil the cellular makeup of our healthy tendons. This unprecedented multidisciplinary approach will create the first ever blueprints of healthy tendons from across multiple anatomical sites in the human body.
5 June 2019
A new study by researchers at NDORMS, University of Oxford now published in Osteoarthritis and Cartilage found that the average lifetime risk of needing further surgery following knee and hip replacement – revision surgery – was around 5% after knee replacement and 8% after hip replacement, with neither body mass index (BMI, combining an individual's height and weight) or smoking having any meaningful effect on these risks.
29 May 2019
Pioneering research by scientists at the Universities of Oxford and Birmingham published today in Nature brings us a step closer to developing targeted therapies for inflammatory diseases.
28 May 2019
New research at the Kennedy Institute reveals potential of a novel class of drugs for the treatment of rheumatoid arthritis.
16 May 2019
The Centre for Statistics in Medicine (CSM) has been awarded £2.5m by Cancer Research UK to advance a programme of work for research on research, developing crucial methodology and key guidelines for excellent medical research.
7 May 2019
Dr Fiona Watt has been awarded a prestigious UK Research and Innovation (UKRI) Future Leaders Fellowship to further her research for better treatments for people living with, or at risk of the commonest form of arthritis, osteoarthritis.
18 April 2019
A recent study by researchers at the University of Oxford and Koç University in Istanbul revealed new epigenetic inhibitors that substantially increase the efficiency of induced pluripotent stem cell (iPSC) generation by overcoming intrinsic somatic cell barriers.
18 April 2019
Two articles from the Kennedy Institute review the latest in understanding immune control in the gut and skin and explain how this knowledge is being translated into new treatments for inflammatory disease
Oxford and partners appoint Professor David Beard and Professor Michael Douek as the new Rosetrees RCS Directors of SITU
17 April 2019
The University of Oxford, in partnership with the Royal College of Surgeons (RCS) and the Rosetrees Trust, are delighted to announce two new professorial posts.
1 April 2019
Dr Liye Chen has been awarded a Versus Arthritis five-year career development fellowship to identify and validate new T cell therapeutic targets in ankylosing spondylitis (AS).
27 March 2019
A recent workshop at Pembroke College, Oxford, provided a showcase for research within the Arthritis Therapy Acceleration Programme (A-TAP) aimed at speeding up the delivery of new drugs for immune-mediated inflammatory disease (IMIDs).
4 March 2019
Researchers from the University of Oxford and Estonia have found further evidence that a person’s genetic make-up and height can influence whether they will develop carpal tunnel syndrome (CTS).
20 February 2019
Need for further surgery particularly high in younger men and serious complications surprisingly common in older people, say researchers.
18 February 2019
The Oxford Centre for Microbiome Studies (OCMS) provides unique access to essential technologies to speed up our understanding of how the microbes that inhabit our bodies influence health and disease.
New drug class could offer a targeted safer treatment alternative for patients with rheumatoid arthritis
15 February 2019
A new treatment targeting tenascin-C could reduce the progression and severity of rheumatoid arthritis (RA) at the very early stages of disease.